230 related articles for article (PubMed ID: 19358226)
21. Antidepressants and antipsychotics classified with torsades de pointes arrhythmia risk and mortality in older adults - a Swedish nationwide study.
Danielsson B; Collin J; Jonasdottir Bergman G; Borg N; Salmi P; Fastbom J
Br J Clin Pharmacol; 2016 Apr; 81(4):773-83. PubMed ID: 26574175
[TBL] [Abstract][Full Text] [Related]
22. Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse.
Swank KA; Wu E; Kortepeter C; McAninch J; Levin RL
J Am Pharm Assoc (2003); 2017; 57(2S):S63-S67. PubMed ID: 28073687
[TBL] [Abstract][Full Text] [Related]
23. An experimental investigation of masking in the US FDA adverse event reporting system database.
Wang HW; Hochberg AM; Pearson RK; Hauben M
Drug Saf; 2010 Dec; 33(12):1117-33. PubMed ID: 21077702
[TBL] [Abstract][Full Text] [Related]
24. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.
Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M
Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028
[TBL] [Abstract][Full Text] [Related]
25. [Shortening of donepezil-induced QTc prolongation with a change in the interacting drug, after electrocardiograph monitoring by community pharmacists: a case report].
Shinozaki K
Yakugaku Zasshi; 2012; 132(2):237-41. PubMed ID: 22293706
[TBL] [Abstract][Full Text] [Related]
26. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database.
Motola D; Piccinni C; Biagi C; Raschi E; Marra A; Marchesini G; Poluzzi E
Drug Saf; 2012 Apr; 35(4):315-23. PubMed ID: 22376166
[TBL] [Abstract][Full Text] [Related]
28. Torsades de pointes associated with fluoroquinolones.
Owens RC; Ambrose PG
Pharmacotherapy; 2002 May; 22(5):663-8; discussion 668-72. PubMed ID: 12013370
[TBL] [Abstract][Full Text] [Related]
29. How safe are recently FDA-approved antimicrobials? A review of the FDA adverse event reporting system database.
Khadem TM; van Manen RP; Brown J
Pharmacotherapy; 2014 Dec; 34(12):1324-9. PubMed ID: 25421400
[TBL] [Abstract][Full Text] [Related]
30. The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database.
Raschi E; Piccinni C; Poluzzi E; Marchesini G; De Ponti F
Acta Diabetol; 2013 Aug; 50(4):569-77. PubMed ID: 22008948
[TBL] [Abstract][Full Text] [Related]
31. Drug-induced QT prolongation and torsade de pointes: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database.
Li D; Chai S; Wang H; Dong J; Qin C; Du D; Wang Y; Du Q; Liu S
Front Pharmacol; 2023; 14():1259611. PubMed ID: 38186652
[No Abstract] [Full Text] [Related]
32. Statin-associated lower urinary tract symptoms: data mining of the public version of the FDA adverse event reporting system, FAERS.
Fujimoto M; Hosomi K; Takada M
Int J Clin Pharmacol Ther; 2014 Apr; 52(4):259-66. PubMed ID: 24472404
[TBL] [Abstract][Full Text] [Related]
33. Drug-versus-drug adverse event rate comparisons: a pilot study based on data from the US FDA Adverse Event Reporting System.
Hochberg AM; Pearson RK; O'Hara DJ; Reisinger SJ
Drug Saf; 2009; 32(2):137-46. PubMed ID: 19236120
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany.
Sarganas G; Garbe E; Klimpel A; Hering RC; Bronder E; Haverkamp W
Europace; 2014 Jan; 16(1):101-8. PubMed ID: 23833046
[TBL] [Abstract][Full Text] [Related]
35. Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS.
Kadoyama K; Kuwahara A; Yamamori M; Brown JB; Sakaeda T; Okuno Y
J Exp Clin Cancer Res; 2011 Oct; 30(1):93. PubMed ID: 21970649
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of drug safety information using large-scale adverse drug reactions database].
Morikawa K
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2011; (129):1-26. PubMed ID: 22259840
[TBL] [Abstract][Full Text] [Related]
37. Long-term proarrhythmic pharmacotherapy among patients with congenital long QT syndrome and risk of arrhythmia and mortality.
Weeke PE; Kellemann JS; Jespersen CB; Theilade J; Kanters JK; Hansen MS; Christiansen M; Marstrand P; Gislason GH; Torp-Pedersen C; Bundgaard H; Jensen HK; Tfelt-Hansen J
Eur Heart J; 2019 Oct; 40(37):3110-3117. PubMed ID: 31079148
[TBL] [Abstract][Full Text] [Related]
38. Platinum agent-induced hypersensitivity reactions: data mining of the public version of the FDA adverse event reporting system, AERS.
Sakaeda T; Kadoyama K; Yabuuchi H; Niijima S; Seki K; Shiraishi Y; Okuno Y
Int J Med Sci; 2011; 8(4):332-8. PubMed ID: 21611115
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the potential of clozapine to cause torsade de pointes.
Warner B; Hoffmann P
Adverse Drug React Toxicol Rev; 2002; 21(4):189-203. PubMed ID: 12503253
[TBL] [Abstract][Full Text] [Related]
40. Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
Szarfman A; Tonning JM; Levine JG; Doraiswamy PM
Pharmacotherapy; 2006 Jun; 26(6):748-58. PubMed ID: 16716128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
